Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217613 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07217613 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants.
The verdict
NCT07217613, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the incidence of early postoperative skin complications including allergic contact dermatitis, blistering, and erythema between silk fibroin incision dressings and cyanoacrylate closure in patients undergoing anterior cruciate ligament reconstruction.
Interventions
- DEVICE silk fibroin-based incision dressing
- DEVICE cyanoacrylate-based closure system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217613
The ClinicalTrials.gov registry entry for NCT07217613 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which silk fibroin-based incision dressing is the first listed.
NCT07217613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07217613 about?
NCT07217613 is a clinical study titled "Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction". The purpose of this study is to compare the incidence of early postoperative skin complications including allergic contact dermatitis, blistering, and erythema between silk fibroin incision dressings and cyanoacrylate closure in patients undergoing anterior cruciate ligament reconstruction.
What is the current status of trial NCT07217613?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-14. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07217613?
The interventions under investigation include: silk fibroin-based incision dressing (DEVICE), cyanoacrylate-based closure system (DEVICE).
Who is sponsoring clinical trial NCT07217613?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.